Laura E. Geldmaker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laura E. Geldmaker has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- David D. Thiel
Department of Urology, Mayo Clinic Florida, Jacksonville, Florida, USA
4 shared publications Bryce A. Baird
Department of Urology, Mayo Clinic, Jacksonville, Florida
2 shared publications- Bryce A. Baird
Department of Urology Mayo Clinic Jacksonville Florida USA
2 shared publications Colleen T. Ball
Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, Florida
2 shared publicationsDaniela A. Haehn
Department of Urology, Mayo Clinic, Jacksonville, Florida
2 shared publications- Daniela A. Haehn
Department of Urology, Mayo Clinic, Jacksonville, FL
2 shared publications
Latest Publications
- 13 July 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-7
Association of day of surgery and distance traveled with length of stay in patients undergoing robotic-assisted partial nephrectomy (RAPN) at a tertiary medical center
The objective of this study is to analyze the association between surgical day of the week and distance traveled with prolonged length of stay (LOS) following robotic-assisted partial nephrectomy (RAPN). 563 consecutive RAPN performed by a single surgeon were evaluated. Early week RAPN was considered Monday through Wednesday, while late-week RAPN was defined as surgery performed Thursday through Friday. Distance traveled for RAPN was evaluated as greater than or less than 60 miles. The respective groups were compared to see if the surgical day of the week or distance traveled influenced the hospital stay or prolonged hospital stay (defined as hospital length of stay equal or greater than 3 days). Overall, 213 patients (38.0%) undergoing RAPN experienced a prolonged LOS. A total of 380 patients underwent early week RAPN compared to 183 late-week RAPN. Patients undergoing late-week RAPN were more likely to have a prolonged LOS compared to early week RAPN (n = 81, 44% vs. n = 133, 35%, respectively; p = 0.004). 229 patients traveled less than 60 miles, while 332 patients traveled more than 60 miles to receive RAPN. 135 patients (40.7%) traveling more than 60 miles experienced a prolonged stay compared to 78 patients (34.1%) traveling less than 60 miles, although this difference was not statistically significant (p = 0.128). Patients who underwent RAPN at the end of the week were more likely to have a prolonged LOS, while distance traveled for RAPN did not appear to affect likelihood of prolonged LOS.
- 13 July 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-7
Association of day of surgery and distance traveled with length of stay in patients undergoing robotic-assisted partial nephrectomy (RAPN) at a tertiary medical center
The objective of this study is to analyze the association between surgical day of the week and distance traveled with prolonged length of stay (LOS) following robotic-assisted partial nephrectomy (RAPN). 563 consecutive RAPN performed by a single surgeon were evaluated. Early week RAPN was considered Monday through Wednesday, while late-week RAPN was defined as surgery performed Thursday through Friday. Distance traveled for RAPN was evaluated as greater than or less than 60 miles. The respective groups were compared to see if the surgical day of the week or distance traveled influenced the hospital stay or prolonged hospital stay (defined as hospital length of stay equal or greater than 3 days). Overall, 213 patients (38.0%) undergoing RAPN experienced a prolonged LOS. A total of 380 patients underwent early week RAPN compared to 183 late-week RAPN. Patients undergoing late-week RAPN were more likely to have a prolonged LOS compared to early week RAPN (n = 81, 44% vs. n = 133, 35%, respectively; p = 0.004). 229 patients traveled less than 60 miles, while 332 patients traveled more than 60 miles to receive RAPN. 135 patients (40.7%) traveling more than 60 miles experienced a prolonged stay compared to 78 patients (34.1%) traveling less than 60 miles, although this difference was not statistically significant (p = 0.128). Patients who underwent RAPN at the end of the week were more likely to have a prolonged LOS, while distance traveled for RAPN did not appear to affect likelihood of prolonged LOS.
- 1 January 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (1) , 40-46
Creation of a Novel, Race-Adjusted, and Risk-Adapted Scoring System to Predict Positive Surgical Margins and Prolonged Operative Time During Robotic Radical Prostatectomy
Objectives: To compare racial differences and pelvis dimensions between Caucasians and African Americans and to develop a risk calculator and scoring system to predict the risk of prolonged operative time and presence of PSM based on these dimensions. Materials and Methods: A retrospective review of 88 consecutive patients undergoing RALP with a pre-operative prostate MRI was conducted. Data extraction included demographic, perioperative, and postoperative oncologic outcomes. PSA was obtained within 3 months post-surgery. Wilcoxon rank sum and Fisher’s exact tests were used to compare continuous and categorical data, respectively. Single and multivariable regression analysis were used to determine contribution of each factor to the composite outcomes.. A risk score was created based on this analysis for predicting the composite outcome. Results: We identified 88 consecutive patients with localized prostate cancer that underwent a pre-operative prostate MRI. No statistically significant differences were found with respect to age, BMI or any post-operative outcome. PSA was lower at diagnosis (6.49 vs 9.72, p=0.006) and operative times were shorter in Caucasians.. Rates of PSM (13 vs 14, p=0.35), BCR (4 vs 2, p=0.69), and complications did not vary between the groups. Caucasians had wider/shallower pelvis dimensions. Based on these variables, we found that the log(odds of OR time >3 hours or PSM) = -5.333 + 1.158 (if African American) + 0.105*PSA + 0.076*F -0.035*G with an AUROCC=0.73. Using the predefined variables, patients can be risk stratified for PSM or prolonged operative times. Conclusions: Several pelvis dimensions were found to be shorter/narrower in African Americans and were associated with longer operative times. The presented risk calculator and stratification system may be used to predict prolonged operative time or having PSM.
- 1 January 2024
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (1) , 40-46
Creation of a Novel, Race-Adjusted, and Risk-Adapted Scoring System to Predict Positive Surgical Margins and Prolonged Operative Time During Robotic Radical Prostatectomy
Objectives: To compare racial differences and pelvis dimensions between Caucasians and African Americans and to develop a risk calculator and scoring system to predict the risk of prolonged operative time and presence of PSM based on these dimensions. Materials and Methods: A retrospective review of 88 consecutive patients undergoing RALP with a pre-operative prostate MRI was conducted. Data extraction included demographic, perioperative, and postoperative oncologic outcomes. PSA was obtained within 3 months post-surgery. Wilcoxon rank sum and Fisher’s exact tests were used to compare continuous and categorical data, respectively. Single and multivariable regression analysis were used to determine contribution of each factor to the composite outcomes.. A risk score was created based on this analysis for predicting the composite outcome. Results: We identified 88 consecutive patients with localized prostate cancer that underwent a pre-operative prostate MRI. No statistically significant differences were found with respect to age, BMI or any post-operative outcome. PSA was lower at diagnosis (6.49 vs 9.72, p=0.006) and operative times were shorter in Caucasians.. Rates of PSM (13 vs 14, p=0.35), BCR (4 vs 2, p=0.69), and complications did not vary between the groups. Caucasians had wider/shallower pelvis dimensions. Based on these variables, we found that the log(odds of OR time >3 hours or PSM) = -5.333 + 1.158 (if African American) + 0.105*PSA + 0.076*F -0.035*G with an AUROCC=0.73. Using the predefined variables, patients can be risk stratified for PSM or prolonged operative times. Conclusions: Several pelvis dimensions were found to be shorter/narrower in African Americans and were associated with longer operative times. The presented risk calculator and stratification system may be used to predict prolonged operative time or having PSM.
- 1 July 2023
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 10 (4) , 312-317
Conversion to Disposable Cystoscopes Decreased Post-procedure Encounters and Infections Compared to Reusable Cystoscopes
To evaluate for differences in post-procedure 30-day encounters or infections following office cystoscopy using disposable versus reusable cystoscopes. Cystoscopies performed from June - September 2020 and February - May 2021 in our outpatient practice were retrospectively reviewed. The 2020 cystoscopies were performed with reusable cystoscopes and the 2021 cystoscopies were performed with disposable cystoscopes (Ambu Inc., Columbia, MD, USA). The primary outcome was the number of post-procedural 30-day encounters defined as phone calls, patient portal messages, emergency department visits, hospitalizations or clinic appointments related to post-procedural complications such as dysuria, hematuria, or fever. Culture-proven urinary tract infection within 30 days of cystoscopy was evaluated as a secondary outcome. We identified 1,000 cystoscopies, including 494 with disposable cystoscopes and 506 with reusable cystoscopes. Demographics were similar between groups. The most common indication for cystoscopy in both groups was suspicion of bladder cancer [disposable: 153 (30.2%) and reusable: 143 (28.9%)]. Reusable cystoscopes were associated with a higher number of 30-day encounters [35 (7.1%) vs. 11 (2.2%), P < .001], urine cultures [73 (14.8%) vs. 3 (0.6%), P = .005], and hospitalizations attributable to cystoscopy [1 (0.2%) vs. 0 (0%), P<.001] than the disposable scope group. Positive urine cultures were also significantly more likely after cystoscopy with a reusable cystoscope [17 (3.4%) vs. 1 (0.2%), P < .001]. Disposable cystoscopes were associated with a lower number of post-procedure encounters and positive urine cultures compared to reusable cystoscopes.
- 1 July 2023
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 10 (4) , 312-317
Conversion to Disposable Cystoscopes Decreased Post-procedure Encounters and Infections Compared to Reusable Cystoscopes
To evaluate for differences in post-procedure 30-day encounters or infections following office cystoscopy using disposable versus reusable cystoscopes. Cystoscopies performed from June - September 2020 and February - May 2021 in our outpatient practice were retrospectively reviewed. The 2020 cystoscopies were performed with reusable cystoscopes and the 2021 cystoscopies were performed with disposable cystoscopes (Ambu Inc., Columbia, MD, USA). The primary outcome was the number of post-procedural 30-day encounters defined as phone calls, patient portal messages, emergency department visits, hospitalizations or clinic appointments related to post-procedural complications such as dysuria, hematuria, or fever. Culture-proven urinary tract infection within 30 days of cystoscopy was evaluated as a secondary outcome. We identified 1,000 cystoscopies, including 494 with disposable cystoscopes and 506 with reusable cystoscopes. Demographics were similar between groups. The most common indication for cystoscopy in both groups was suspicion of bladder cancer [disposable: 153 (30.2%) and reusable: 143 (28.9%)]. Reusable cystoscopes were associated with a higher number of 30-day encounters [35 (7.1%) vs. 11 (2.2%), P < .001], urine cultures [73 (14.8%) vs. 3 (0.6%), P = .005], and hospitalizations attributable to cystoscopy [1 (0.2%) vs. 0 (0%), P<.001] than the disposable scope group. Positive urine cultures were also significantly more likely after cystoscopy with a reusable cystoscope [17 (3.4%) vs. 1 (0.2%), P < .001]. Disposable cystoscopes were associated with a lower number of post-procedure encounters and positive urine cultures compared to reusable cystoscopes.
- 24 August 2022
- Published by Wiley in International Journal of Urology
- Vol. 29 (12) , 1439-1444
Validation of new baseline renal function predictive model in robotic‐assisted partial nephrectomy cohort
Objective: To validate a new baseline estimated glomerular filtration rate (NB‐GFR) formula in a cohort of robotic‐assisted partial nephrectomies (RAPN).Methods: NB‐GFR = 35 + preoperative GFR (× 0.65) – 18 (if radical nephrectomy) – age (× 0.25) + 3 (if tumor size >7 cm) – 2 (if diabetes). NB‐GFR was calculated in 464 consecutive RAPN from a single surgeon cohort. 143 patients were excluded secondary to insufficient eGFR follow up. We analyzed NB‐GFR accuracy utilizing the last observed eGFR 3–12 months post RAPN. Categorical variables were summarized with the frequency and percentage of patients. Numerical variables were summarized with the median, 25th percentile, and 75th percentile.Results: The mean difference between observed and predicted NB‐GFR was 4.6 ml/min/1.73m2 (95% CI −6.9 to 16.1 ml/min/1.73m2). There was a pattern of higher observed NB‐GFRs being underestimated by the NB‐GFR equation while lower observed NB‐GFRs were overestimated by the NB‐GFR equation. The NB‐GFR formula had a high level of accuracy with 98.8% of predicted NB‐GFRs falling within 30% of the observed NB‐GFR (95% CI 86.8% to 99.5%). The median and interquartile range of the difference between observed and predicted NB‐GFR was 3.9 ml/min/1.73m2 (IQR 0.7 to 8.2 ml/min/1.73m2). The sensitivity, specificity, positive predictive value, and negative predictive value for the ability of predicted NB‐GFR to identify those with an observed NB‐GFR 2 after RAPN was 98%, 92%, 88%, and 99%, respectively.Conclusion: The NB‐GFR equation developed with partial and radical nephrectomy cohorts is accurate in predicting post‐operative eGFR 3–12 months following RAPN.
- 24 August 2022
- Published by Wiley in International Journal of Urology
- Vol. 29 (12) , 1439-1444
Validation of new baseline renal function predictive model in robotic‐assisted partial nephrectomy cohort
Objective: To validate a new baseline estimated glomerular filtration rate (NB‐GFR) formula in a cohort of robotic‐assisted partial nephrectomies (RAPN).Methods: NB‐GFR = 35 + preoperative GFR (× 0.65) – 18 (if radical nephrectomy) – age (× 0.25) + 3 (if tumor size >7 cm) – 2 (if diabetes). NB‐GFR was calculated in 464 consecutive RAPN from a single surgeon cohort. 143 patients were excluded secondary to insufficient eGFR follow up. We analyzed NB‐GFR accuracy utilizing the last observed eGFR 3–12 months post RAPN. Categorical variables were summarized with the frequency and percentage of patients. Numerical variables were summarized with the median, 25th percentile, and 75th percentile.Results: The mean difference between observed and predicted NB‐GFR was 4.6 ml/min/1.73m2 (95% CI −6.9 to 16.1 ml/min/1.73m2). There was a pattern of higher observed NB‐GFRs being underestimated by the NB‐GFR equation while lower observed NB‐GFRs were overestimated by the NB‐GFR equation. The NB‐GFR formula had a high level of accuracy with 98.8% of predicted NB‐GFRs falling within 30% of the observed NB‐GFR (95% CI 86.8% to 99.5%). The median and interquartile range of the difference between observed and predicted NB‐GFR was 3.9 ml/min/1.73m2 (IQR 0.7 to 8.2 ml/min/1.73m2). The sensitivity, specificity, positive predictive value, and negative predictive value for the ability of predicted NB‐GFR to identify those with an observed NB‐GFR 2 after RAPN was 98%, 92%, 88%, and 99%, respectively.Conclusion: The NB‐GFR equation developed with partial and radical nephrectomy cohorts is accurate in predicting post‐operative eGFR 3–12 months following RAPN.
- Open Access
- 23 June 2022
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 6 (4) , 373-380
Impact of Severe Acute Respiratory Syndrome Coronavirus 2-Induced COVID-19 on Fixed Operating Room Times in Urologic Operations
- 23 June 2022
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 6 (4) , 373-380
Open AccessImpact of Severe Acute Respiratory Syndrome Coronavirus 2-Induced COVID-19 on Fixed Operating Room Times in Urologic Operations
- Open Access
- 17 March 2022
- Published by Elsevier in Urology Case Reports
- Vol. 43, 102054
Robotic transvesical bladder leiomyoma excision
- 17 March 2022
- Published by Elsevier in Urology Case Reports
- Vol. 43, 102054
Open AccessRobotic transvesical bladder leiomyoma excision